Experienced in Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH)

Hiroji Uemura

Yokohama, JP 
Experienced in Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH)
Yokohama, JP 
OverviewLocationsClinical Research

Overview

Hiroji Uemura practices in Yokohama, Japan. Uemura is rated as an Experienced expert by MediFind in the treatment of Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH). Their top areas of expertise are Prostate Cancer, Bladder Stones, Hydronephrosis, Kidney Transplant, and Penectomy.

Their clinical research consists of co-authoring 338 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH).

Locations

Yokohama, Japan
Other Locations
Kamakura, Japan
Sayama, Japan
Kyoto, Japan
Osaka, Japan
Tokushima, Japan
Kashiwa, 2778561, Japan
Yokoyama, 2360004, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

CYCLONE 3: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Abemaciclib in Combination With Abiraterone Plus Prednisone in Men With High-Risk Metastatic Hormone-Sensitive Prostate Cancer
CYCLONE 3: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Abemaciclib in Combination With Abiraterone Plus Prednisone in Men With High-Risk Metastatic Hormone-Sensitive Prostate Cancer
Enrollment Status: Active_not_recruiting
Publish Date: June 27, 2025
Intervention Type: Drug
Study Phase: Phase 3
A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib in Patients With Metastatic Castration-Resistant Prostate Cancer
A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib in Patients With Metastatic Castration-Resistant Prostate Cancer
Enrollment Status: Active_not_recruiting
Publish Date: April 20, 2025
Intervention Type: Drug
Study Drugs: Abemaciclib, Abiraterone Acetate, Prednisone
Study Phase: Phase 2/Phase 3
A Phase 1 Study of Abemaciclib in Combination With Other Anti-Cancer Therapy in Japanese Patients With Advanced Cancer
A Phase 1 Study of Abemaciclib in Combination With Other Anti-Cancer Therapy in Japanese Patients With Advanced Cancer
Enrollment Status: Completed
Publish Date: September 21, 2021
Intervention Type: Drug
Study Phase: Phase 1
View 2 Less Clinical Trials

338 Total Publications

Current Status and Prospects of RI Internal Therapy for Prostate Cancer
Current Status and Prospects of RI Internal Therapy for Prostate Cancer
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: August 21, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Uemura's expertise for a condition
ConditionClose
View All 14 Advanced Conditions
View All 43 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile